Click a link below to view the mailing archive as if it had been sent to you.
| 2013-10-31 12:15 | | EntreMed commences ENMD-2076 Phase 2 trial and more... |
| 2013-10-31 00:15 | | J&J's Janssen Must Pay $4 Million Over Topamax, Jury Says and more... |
| 2013-10-30 12:15 | | Questcor Pharma shares sink after drugmaker updates analysts on government investigation and more... |
| 2013-10-30 00:15 | | Pfizer Profit Gets Help From Cancer-Fighting Unit and more... |
| 2013-10-29 12:15 | | United Therapeutics profit misses estimates as expenses rise and more... |
| 2013-10-29 00:15 | | 4 Healthcare Stock Stories Getting Noticed on Monday and more... |
| 2013-10-28 12:15 | | Top 10 Drug Patent Losses of 2014 and more... |
| 2013-10-28 00:15 | | Now, US FDA gets a call from Indian pharma companies and more... |
| 2013-10-26 12:15 | | Is It Pharma's Fault That We Don't Have Better Drugs For Malaria, TB And Tropical Diseases? and more... |
| 2013-10-26 00:15 | | Q3 Earnings Roundup for Pharmaceutical Stocks and more... |
| 2013-10-25 12:15 | | Allergan (AGN) Earnings Projected to Increase and more... |
| 2013-10-25 00:15 | | Earnings Preview: Merck to report 3Q results and more... |
| 2013-10-24 12:15 | | Diabetes Giants Battle Outside of Their Usual Arena and more... |
| 2013-10-24 00:15 | | Amarin slashes staff by half after FDA panel rejection and more... |
| 2013-10-23 12:15 | | Samsung, Roche in biologics manufacturing deal and more... |
| 2013-10-23 00:15 | | Merck Heart Drug Runs Into New Worry and more... |
| 2013-10-22 12:15 | | Reckitt Benckiser reviews pharma unit, could sell it and more... |
| 2013-10-22 00:15 | | Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib and more... |
| 2013-10-21 12:15 | | Medtronic launches Export Advance catheter in the U.S. and more... |
| 2013-10-21 00:15 | | China Biotech In Review: WuXi Laboratory The Only CLIA-Certified Clinical Lab In China and more... |
| 2013-10-20 00:15 | | Iroko Pharmaceuticals Receives FDA Approval for ZORVOLEX and more... |
| 2013-10-19 00:15 | | Drug use, spending varies widely in U.S. by region and more... |
| 2013-10-18 12:15 | | GE Healthcare boosts Q3 profits despite flat sales and more... |
| 2013-10-18 00:15 | | Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline and more... |
| 2013-10-17 12:15 | | AstraZeneca, Amgen Crohn's drug runs into PhII 'logistical' snafu and more... |
| 2013-10-17 00:15 | | FDA panel rejects expanded use of Amarin's Vascepa amid questions for fish oil drug and more... |
| 2013-10-16 12:15 | | Former Bayer Employee Can Proceed With Whistleblower Lawsuit and more... |
| 2013-10-16 00:15 | | Arena Will Double Sales Force For Belviq and more... |
| 2013-10-15 12:15 | | 4 Biotechnology Stocks With Room To Climb and more... |
| 2013-10-15 00:15 | | McClellan To The Rescue? J&J Adds Former FDA Commish On Board |
| 2013-10-14 12:15 | | Guided Therapeutics widens distribution after FDA disappointment and more... |
| 2013-10-14 00:15 | | China Biotech In Review: Hutchison MediPharma Partners Cancer Drug With Lilly and more... |
| 2013-10-13 00:15 | | Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals and more... |
| 2013-10-12 12:15 | | Is This Single-Drug Company Still a Good Investment? and more... |
| 2013-10-12 00:15 | | KV's first steps after emerging from bankruptcy and more... |
| 2013-10-11 12:15 | | Nicotine patch maker LTS Lohmann attracts bidders and more... |
| 2013-10-11 00:15 | | Genmab announces positive results for sclerosis drug candidate and more... |
| 2013-10-10 12:15 | | Quest Diagnostics says third-quarter profit to miss estimates and more... |
| 2013-10-10 00:15 | | 7 Disruptive Drugs for the Next Decade and more... |
| 2013-10-09 12:15 | | Ex-Celgene, Sanofi execs plead guilty on insider trading charges and more... |
| 2013-10-09 00:15 | | Novartis - Make Money From COPD Opportunity and more... |
| 2013-10-08 12:15 | | Post-restructuring, Pfizer R&D focused on its top blockbuster prospects and more... |
| 2013-10-08 00:15 | | Forget drug-sales forecasts, study finds: They're mostly wrong and more... |
| 2013-10-07 12:15 | | Experts thinks Biogen to likely be able to market Tecfidera in EU, says Leerink and more... |
| 2013-10-06 12:15 | | Teva announces Copaxone patent win and more... |
| 2013-10-05 12:15 | | 'Obamacare' boost to Indian pharmaceutical industry and more... |
| 2013-10-05 00:15 | | Bill Weldon gets new chairman title at Chase Bank and more... |
| 2013-10-04 12:15 | | Should Drugmakers Pay Punitive Damages? Novartis Says No and more... |
| 2013-10-04 00:15 | | J&J makes an R&D splash with $42M venture play, biotech collaborations and more... |
| 2013-10-03 12:15 | | New Type of Drug to Lower LDL Looks Promising and more... |
| 2013-10-03 00:15 | | Judge sweeps aside AstraZeneca shield against Nexium competitor and more... |
| 2013-10-02 12:15 | | Cancer immunotherapies turn a corner in race to megablockbuster market and more... |
| 2013-10-02 00:15 | | Merck drug triggers response in 24 pct of lung cancer patients and more... |
| 2013-10-01 12:15 | | Geron unloads its stem cell coffers to BioTime in stock deal and more... |
| 2013-10-01 00:15 | | Roche's new round of lung cancer data keeps spotlight on immunotherapies and more... |
